Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-006310
Filing Date
2015-08-07
Accepted
2015-08-07 15:59:12
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q once-201563010xq.htm 10-Q 901139
2 EXHIBIT 31.1 once2015630ex-311.htm EX-31.1 19977
3 EXHIBIT 31.2 once2015630ex-312.htm EX-31.2 19976
4 EXHIBIT 32.1 once2015630ex-321.htm EX-32.1 6895
5 EXHIBIT 32.2 once2015630ex-322.htm EX-32.2 6779
  Complete submission text file 0001628280-15-006310.txt   3379024

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT once-20150630.xml EX-101.INS 380368
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT once-20150630.xsd EX-101.SCH 29592
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT once-20150630_cal.xml EX-101.CAL 34249
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT once-20150630_def.xml EX-101.DEF 159759
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT once-20150630_lab.xml EX-101.LAB 417104
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT once-20150630_pre.xml EX-101.PRE 242376
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36819 | Film No.: 151037237
SIC: 2836 Biological Products, (No Diagnostic Substances)